External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection
Open Access
- 9 January 2021
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Gastroenterology
Abstract
One in four patients with primary Clostridioides difficile infection (CDI) develops recurrent CDI (rCDI). With every recurrence, the chance of a subsequent CDI episode increases. Early identification of patients at risk for rCDI might help doctors to guide treatment. The aim of this study was to externally validate published clinical prediction tools for rCDI. The validation cohort consisted of 129 patients, diagnosed with CDI between 2018 and 2020. rCDI risk scores were calculated for each individual patient in the validation cohort using the scoring tools described in the derivation studies. Per score value, we compared the average predicted risk of rCDI with the observed number of rCDI cases. Discrimination was assessed by calculating the area under the receiver operating characteristic curve (AUC). Two prediction tools were selected for validation (Cobo 2018 and Larrainzar-Coghen 2016). The two derivation studies used different definitions for rCDI. Using Cobo’s definition, rCDI occurred in 34 patients (26%) of the validation cohort: using the definition of Larrainzar-Coghen, we observed 19 recurrences (15%). The performance of both prediction tools was poor when applied to our validation cohort. The estimated AUC was 0.43 [95% confidence interval (CI); 0.32–0.54] for Cobo’s tool and 0.42 (95% CI; 0.28–0.56) for Larrainzar-Coghen’s tool. Performance of both prediction tools was disappointing in the external validation cohort. Currently identified clinical risk factors may not be sufficient for accurate prediction of rCDI.Keywords
This publication has 45 references indexed in Scilit:
- Electronic Health Record–Based Detection of Risk Factors for Clostridium difficile Infection RelapseInfection Control & Hospital Epidemiology, 2013
- Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based StudyMayo Clinic Proceedings, 2012
- Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial ManagementClinical Infectious Diseases, 2012
- Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin ProductionJournal of Bacteriology, 2010
- Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomesJournal of Infection, 2009
- Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile InfectionGastroenterology, 2009
- Reining in Recurrent Clostridium difficile Infection—Who's at Risk?Gastroenterology, 2009
- Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078Clinical Infectious Diseases, 2008
- Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1Journal of Clinical Microbiology, 2008
- Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolatesClinical Microbiology & Infection, 2007